CT Abdomen and Pelvis Without IV Contrast There is no relevant literature to support the use of CT abdomen and pelvis without IV contrast (separate from CTU) in the evaluation of MIBC. CT Abdomen With IV Contrast There is no relevant literature to support the use of CT abdomen with IV contrast (separate from CTU) in the evaluation of MIBC. CT Abdomen Without and With IV Contrast There is no relevant literature to support the use of CT abdomen without and with IV contrast (separate from CTU) in the evaluation of MIBC. Pretreatment Staging of Urothelial Cancer CT Abdomen Without IV Contrast There is no relevant literature to support the use of CT abdomen without IV contrast (separate from CTU) in the evaluation of MIBC. CT Chest With IV Contrast It is recommended that all patients with MIBC undergo pulmonary evaluation [30]. Patients with MIBC who have abnormal chest radiograph findings or are at high risk should undergo chest CT, consistent with other guidelines [31,32]. However, there is currently a lack of original research directly comparing the diagnostic usefulness of chest radiographs versus chest CT in this patient population. CT chest with IV contrast is preferred over CT chest without IV contrast when evaluating for metastatic disease and lymphadenopathy. CT Chest Without and With IV Contrast There is no relevant literature to support the use of CT chest without and with IV contrast in the evaluation of MIBC. There is no additional benefit to support performing CT chest without and with contrast over imaging either without or with contrast alone. CT Chest Without IV Contrast It is recommended that all patients with MIBC undergo pulmonary evaluation [30]. Patients with MIBC who have abnormal chest radiograph findings or are at high risk should undergo chest CT, consistent with other guidelines [31,32].
Pretreatment Staging of Urothelial Cancer. CT Abdomen and Pelvis Without IV Contrast There is no relevant literature to support the use of CT abdomen and pelvis without IV contrast (separate from CTU) in the evaluation of MIBC. CT Abdomen With IV Contrast There is no relevant literature to support the use of CT abdomen with IV contrast (separate from CTU) in the evaluation of MIBC. CT Abdomen Without and With IV Contrast There is no relevant literature to support the use of CT abdomen without and with IV contrast (separate from CTU) in the evaluation of MIBC. Pretreatment Staging of Urothelial Cancer CT Abdomen Without IV Contrast There is no relevant literature to support the use of CT abdomen without IV contrast (separate from CTU) in the evaluation of MIBC. CT Chest With IV Contrast It is recommended that all patients with MIBC undergo pulmonary evaluation [30]. Patients with MIBC who have abnormal chest radiograph findings or are at high risk should undergo chest CT, consistent with other guidelines [31,32]. However, there is currently a lack of original research directly comparing the diagnostic usefulness of chest radiographs versus chest CT in this patient population. CT chest with IV contrast is preferred over CT chest without IV contrast when evaluating for metastatic disease and lymphadenopathy. CT Chest Without and With IV Contrast There is no relevant literature to support the use of CT chest without and with IV contrast in the evaluation of MIBC. There is no additional benefit to support performing CT chest without and with contrast over imaging either without or with contrast alone. CT Chest Without IV Contrast It is recommended that all patients with MIBC undergo pulmonary evaluation [30]. Patients with MIBC who have abnormal chest radiograph findings or are at high risk should undergo chest CT, consistent with other guidelines [31,32].